ENCell Co., Ltd.

As of June 30, 2026, ENCell Co., Ltd. carries a market capitalization of 84.60B, placing it among publicly traded companies globally. Its enterprise value stands at 66.34B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, ENCell Co., Ltd. has 11.00M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 20.22, and the price-to-book ratio stands at 3.04.

These figures are as of June 30, 2026. The EV/Sales ratio of 15.93 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 66.34B versus a market cap of 84.60B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, ENCell Co., Ltd. maintains a current ratio of 7.06, meaning it holds 7.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 47.16, indicating elevated leverage, while an interest coverage ratio of -8.51 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, ENCell Co., Ltd. posted a negative return on equity (ROE) of -57.72, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -38.44, reflecting losses generated across the asset base. The company generates approximately 37.18M in revenue per employee across its workforce of 112.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.32 indicates how many times ENCell Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 23, 2026, ENCell Co., Ltd.'s stock has declined approximately 59.52% over the past 52 weeks. The 50-day moving average sits at 5,701.80, while the 200-day moving average is 11,026.93.

Over the twelve months ended June 30, 2026, ENCell Co., Ltd. generated 4.16B in revenue and converted that into -19.62B in net income, yielding earnings per share of -1,791.51. EBITDA reached -13.49B, while operating income came in at -18.15B.

As of June 30, 2026, ENCell Co., Ltd. holds 31.40B in cash and equivalents against 13.14B in total debt, resulting in a net debt position of -11.63B. Total book value stands at 27.86B, with working capital of 30.18B providing operational flexibility.

ENCell Co., Ltd. produced -10.03B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -3.30B in capital expenditures, free cash flow totaled -13.33B - equivalent to -1,217.33 per share.

Over the twelve months ended June 30, 2026, ENCell Co., Ltd. posted a gross margin of -67.43, reflecting its pricing power and cost economics. The operating margin of -435.75 and net profit margin of -471.16 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -15.83: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -26.15, meaning ENCell Co., Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, ENCell Co., Ltd. has an Altman Z-Score of -1.28, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.